Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice
dc.contributor.author | Jiang, Huidi | en_US |
dc.contributor.author | Hu, Yongjun | en_US |
dc.contributor.author | Keep, Richard F. | en_US |
dc.contributor.author | Smith, David E. | en_US |
dc.date.accessioned | 2010-04-01T15:07:28Z | |
dc.date.available | 2010-04-01T15:07:28Z | |
dc.date.issued | 2009-06 | en_US |
dc.identifier.citation | Jiang, Huidi; Hu, Yongjun; Keep, Richard F.; Smith, David E. (2009). "Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice." Journal of Neurochemistry 109(5): 1536-1543. <http://hdl.handle.net/2027.42/65589> | en_US |
dc.identifier.issn | 0022-3042 | en_US |
dc.identifier.issn | 1471-4159 | en_US |
dc.identifier.uri | https://hdl.handle.net/2027.42/65589 | |
dc.identifier.uri | http://www.ncbi.nlm.nih.gov/sites/entrez?cmd=retrieve&db=pubmed&list_uids=19383084&dopt=citation | en_US |
dc.format.extent | 451581 bytes | |
dc.format.extent | 3110 bytes | |
dc.format.mimetype | application/pdf | |
dc.format.mimetype | text/plain | |
dc.publisher | Blackwell Publishing Ltd | en_US |
dc.rights | Journal compilation © 2009 International Society for Neurochemistry | en_US |
dc.subject.other | Aminopeptidase | en_US |
dc.subject.other | Antinociception | en_US |
dc.subject.other | Intracerebroventricular | en_US |
dc.subject.other | Kyotorphin | en_US |
dc.subject.other | Pept2 | en_US |
dc.subject.other | Knockout Mice | en_US |
dc.title | Enhanced antinociceptive response to intracerebroventricular kyotorphin in Pept2 null mice | en_US |
dc.type | Article | en_US |
dc.rights.robots | IndexNoFollow | en_US |
dc.subject.hlbsecondlevel | Neurosciences | en_US |
dc.subject.hlbtoplevel | Health Sciences | en_US |
dc.description.peerreviewed | Peer Reviewed | en_US |
dc.contributor.affiliationum | * Department of Pharmaceutical Sciences, College of Pharmacy, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationum | † Departments of Neurosurgery and Physiology, Medical School, University of Michigan, Ann Arbor, Michigan, USA | en_US |
dc.contributor.affiliationother | † College of Pharmaceutical Sciences, Zhejiang University, Hangzhou, Zhejiang, China | en_US |
dc.identifier.pmid | 19383084 | en_US |
dc.description.bitstreamurl | http://deepblue.lib.umich.edu/bitstream/2027.42/65589/1/j.1471-4159.2009.06090.x.pdf | |
dc.identifier.doi | 10.1111/j.1471-4159.2009.06090.x | en_US |
dc.identifier.source | Journal of Neurochemistry | en_US |
dc.identifier.citedreference | Akasaki K., Nakamura A., Shiomi H. and Tsuji H. ( 1991 ) Identification and characterization of two distinct kyotorphin-hydrolyzing enzymes in rat brain. Neuropeptides 20, 103 – 107. | en_US |
dc.identifier.citedreference | Brandsch M., KnÜtter I. and Bosse-Doenecke E. ( 2008 ) Pharmaceutical and pharmacological importance of peptide transporters. J. Pharm. Pharmacol. 60, 543 – 585. | en_US |
dc.identifier.citedreference | Daniel H. and Kottra G. ( 2004 ) The proton oligopeptide cotransporter family SLC15 in physiology and pharmacology. PflÜgers Arch. 447, 610 – 618. | en_US |
dc.identifier.citedreference | Davis T. P. and Konings P. N. ( 1993 ) Peptidases in the CNS: formation of biologically active, receptor-specific peptide fragments. Crit. Rev. Neurobiol. 7, 163 – 174. | en_US |
dc.identifier.citedreference | Fujita T., Kishida T., Okada N., Ganapathy V., Leibach F. H. and Yamamoto A. ( 1999 ) Interaction of kyotorphin and brain peptide transporter in synaptosomes prepared from rat cerebellum: implication of high affinity type H + /peptide transporter PEPT2 mediated transport system. Neurosci. Lett. 271, 117 – 120. | en_US |
dc.identifier.citedreference | Fujita T., Kishida T., Wada M., Okada N., Yamamoto A., Leibach F. H. and Ganapathy V. ( 2004 ) Functional characterization of brain peptide transporter in rat cerebral cortex: identification of the high-affinity type H + /peptide transporter PEPT2. Brain Res. 997, 52 – 61. | en_US |
dc.identifier.citedreference | Hu Y., Ocheltree S. M., Xiang J., Keep R. F. and Smith D. E. ( 2005 ) Glycyl-L-glutamine disposition in rat choroid plexus epithelial cells in primary culture: role of PEPT2. Pharm. Res. 22, 1281 – 1286. | en_US |
dc.identifier.citedreference | Hu Y., Shen H., Keep R. F. and Smith D. E. ( 2007 ) Peptide transporter 2 (PEPT2) expression in brain protects against 5-aminolevulinic acid neurotoxicity. J. Neurochem. 103, 2058 – 2065. | en_US |
dc.identifier.citedreference | Ikeda T., Waldbillig R. J. and Puro D. G. ( 1995 ) Truncation of IGF-1 yields two mitogens for retinal MÜller glial cells. Brain Res. 686, 87 – 92. | en_US |
dc.identifier.citedreference | Margolis F. L., Grillo M., Hempstead J. and Morgan J. I. ( 1987 ) Monoclonal antibodies to mammalian carnosine synthetase. J. Neurochem. 48, 593 – 600. | en_US |
dc.identifier.citedreference | Matsubayashi K., Kojima C., Kawajiri S., Ono K., Takegoshi T., Ueda H. and Takagi H. ( 1984 ) Hydrolytic deactivation of kyotorphin by the rodent brain homogenates and sera. J. Pharmacobiodyn. 7, 479 – 484. | en_US |
dc.identifier.citedreference | Matsushita H., Suzuki H., Sugiyama Y., Sawada Y., Iga T., Kawaguchi Y. and Hanano M. ( 1991 ) Facilitated transport of cefodizime into the rat central nervous system. J. Pharmacol. Exp. Ther. 259, 620 – 625. | en_US |
dc.identifier.citedreference | Nishimura K., Kaya K., Hazato T., Ueda H., Satoh M. and Takagi H. ( 1991 ) Kyotorphin like substance in human cerebrospinal fluid of patients with persistent pain. Masui 40, 1686 – 1690. | en_US |
dc.identifier.citedreference | Nyberg F. and Hallberg M. ( 2007 ) Peptide conversion – a potential pathway modulating G-protein signaling. Curr. Drug Targets 8, 147 – 154. | en_US |
dc.identifier.citedreference | Ocheltree S. M., Shen H., Hu Y., Keep R. F. and Smith D. E. ( 2005 ) Role and relevance of peptide transporter 2 (PEPT2) in the kidney and choroid plexus: in vivo studies with glycylsarcosine in wild-type and PEPT2 knockout mice. J. Pharmacol. Exp. Ther. 315, 240 – 247. | en_US |
dc.identifier.citedreference | Rubio-Aliaga I. and Daniel H. ( 2008 ) Peptide transporters and their roles in physiological processes and drug disposition. Xenobiotica 38, 1022 – 1042. | en_US |
dc.identifier.citedreference | Rudick R. A., Zirretta D. K. and Herndon R. M. ( 1982 ) Clearance of albumin from mouse subarachnoid space: a measure of CSF bulk flow. J. Neurosci. Methods 6, 253 – 259. | en_US |
dc.identifier.citedreference | Shen H., Smith D. E., Yang T., Huang Y. G., Schnermann J. B. and Brosius III F. C. ( 1999 ) Localization of PEPT1 and PEPT2 proton-coupled oligopeptide transporter mRNA and protein in rat kidney. Am. J. Physiol. 276, F658 – F665. | en_US |
dc.identifier.citedreference | Shen H., Smith D. E., Keep R. F., Xiang J. and Brosius III F. C. ( 2003 ) Targeted disruption of the PEPT2 gene markedly reduces dipeptide uptake in choroid plexus. J. Biol. Chem. 278, 4786 – 4791. | en_US |
dc.identifier.citedreference | Shen H., Smith D. E., Keep R. F. and Brosius III F. C. ( 2004 ) Immunolocalization of the proton-coupled oligopeptide transporter PEPT2 in developing rat brain. Mol. Pharm. 1, 248 – 256. | en_US |
dc.identifier.citedreference | Shen H., Ocheltree S. M., Hu Y., Keep R. F. and Smith D. E. ( 2007 ) Impact of genetic knockout of PEPT2 on cefadroxil pharmacokinetics, renal tubular reabsorption, and brain penetration in mice. Drug Metab. Dispos. 35, 1209 – 1216. | en_US |
dc.identifier.citedreference | Smith D. E., Johanson C. E. and Keep R. F. ( 2004 ) Peptide and peptide analog transport systems at the blood-CSF barrier. Adv. Drug Deliv. Rev. 56, 1765 – 1791. | en_US |
dc.identifier.citedreference | Suzuki H., Sawada Y., Sugiyama Y., Iga T., Hanano M. and Spector R. ( 1989 ) Transport of imipenem, a novel carbapenem antibiotic, in the rat central nervous system. J. Pharmacol. Exp. Ther. 250, 979 – 984. | en_US |
dc.identifier.citedreference | Takagi H., Shiomi H., Ueda H. and Amano H. ( 1979a ) A novel analgesic dipeptide from bovine brain is a possible Met-enkephalin releaser. Nature 282, 410 – 412. | en_US |
dc.identifier.citedreference | Takagi H., Shiomi H., Ueda H. and Amano H. ( 1979b ) Morphine-like analgesia by a new dipeptide, L-tyrosyl-L-arginine (kyotorphin) and its analogue. Eur. J. Pharmacol. 55, 109 – 111. | en_US |
dc.identifier.citedreference | Terada T., Sawada K., Irie M., Saito H., Hashimoto Y. and Inui K-I. ( 2000 ) Structural requirements for determining the substrate affinity of peptide transporters PEPT1 and PEPT2. PflÜgers Arch. 440, 679 – 684. | en_US |
dc.identifier.citedreference | Teuscher N. S., Keep R. F. and Smith D. E. ( 2001 ) PEPT2-mediated uptake of neuropeptides in rat choroid plexus. Pharm. Res. 18, 807 – 813. | en_US |
dc.identifier.citedreference | Teuscher N. S., Shen H., Shu C., Xiang J., Keep R. F. and Smith D. E. ( 2004 ) Carnosine uptake in rat choroid plexus primary cell cultures and choroid plexus whole tissue from PEPT2 null mice. J. Neurochem. 89, 375 – 382. | en_US |
dc.identifier.citedreference | Thakkar S. V., Miyauchi S., Prasad P. D. and Ganapathy V. ( 2008 ) Stimulation of Na + /Cl - -coupled opioid peptide transport system in SK-N-SH cells by L-kyotorphin, an endogenous substrate for H + -coupled peptide transporter PEPT2. Drug Metab. Pharmacokinet. 23, 254 – 262. | en_US |
dc.identifier.citedreference | Tzingounis A. V. and Wadiche J. I. ( 2007 ) Glutamate transporters: confining runaway excitation by shaping synaptic transmission. Neuroscience 8, 935 – 947. | en_US |
dc.identifier.citedreference | Ueda H. and Inoue M. ( 2000 ) In vivo signal transduction of nociceptive response by kyotorphin (tyrosine-arginine) through Gα i - and inositol triphosphate-mediated Ca 2+ influx. Mol. Pharmacol. 57, 108 – 115. | en_US |
dc.identifier.citedreference | Ueda H., Tatsumi K., Shiomi H. and Takagi H. ( 1982 ) Analgesic dipeptide, kyotorphin (Tyr-Arg), is highly concentrated in the synaptosomal fraction of the rat brain. Brain Res. 231, 222 – 224. | en_US |
dc.identifier.citedreference | Ueda H., Ming G., Hazato T., Katayama T. and Takagi H. ( 1985 ) Degradation of kyotorphin by a purified membrane-bound-aminopeptidase from monkey brain: potentiation of kyotorphin-induced analgesia by a highly effective inhibitor, bestatin. Life Sci. 36, 1865 – 1871. | en_US |
dc.identifier.citedreference | Ueda H., Yoshihara Y., Fukushima N., Shiomi H., Nakamura A. and Takagi H. ( 1987 ) Kyotorphin (tyrosine-arginine) synthetase in rat brain synaptosomes. J. Biol. Chem. 262, 8165 – 8173. | en_US |
dc.identifier.citedreference | Yamashita T., Shimada S., Guo W., Sato K., Kohmura E., Hayakawa T., Takagi T. and Tohyama M. ( 1997 ) Cloning and functional expression of a brain peptide/histidine transporter. J. Biol. Chem. 272, 10205 – 10211. | en_US |
dc.owningcollname | Interdisciplinary and Peer-Reviewed |
Files in this item
Remediation of Harmful Language
The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.
Accessibility
If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.